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Abstract
Feline dysautonomia (FD) is a multiple system neuropathy of unknown aetiology. An appar-
ently identical disease occurs in horses (equine grass sickness, EGS), dogs, rabbits, hares,
sheep, alpacas and llamas. Horses with acute EGS have a marked reduction in plasma con-
centrations of the sulphur amino acids (SAA) cyst(e)ine and methionine, which may reflect
exposure to a neurotoxic xenobiotic. The aim of this study was to determine whether FD
cats have alterations in amino acid profiles similar to those of EGS horses. Amino acids
were quantified in plasma/serum from 14 FD cats, 5 healthy in-contact cats which shared
housing and diet with the FD cats, and 6 healthy control cats which were housed separately
from FD cats and which received a different diet. The adequacy of amino acids in the cats’
diet was assessed by determining the amino acid content of tinned and dry pelleted foods
collected immediately after occurrences of FD. Compared with controls, FD cats had
increased concentrations of many essential amino acids, with the exception of methionine
which was significantly reduced, and reductions in most non-essential amino acids. In-con-
tact cats also had inadequate methionine status. Artefactual loss of cysteine during analysis
precluded assessment of the cyst(e)ine status. Food analysis indicated that the low methio-
nine status was unlikely to be attributable to dietary inadequacy of methionine or cystine.
Multi-mycotoxin screening identified low concentrations of several mycotoxins in dry food
from all 3 premises. While this indicates fungal contamination of the food, none of these
mycotoxins appears to induce the specific clinico-pathologic features which characterise FD
and equivalent multiple system neuropathies in other species. Instead, we hypothesise that
ingestion of another, as yet unidentified, dietary neurotoxic mycotoxin or xenobiotic, may
cause both the characteristic disease pathology and the plasma SAA depletion.
Introduction
Feline dysautonomia (FD) is a multiple system neuropathy first reported in Scotland in 1982
[1]. It is characterised by chromatolysis, degeneration and loss of enteric neurons, peripheral
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and central autonomic neurons, neurons in specific brain stem nuclei and spinal cord somatic
efferent lower motor neurons [2,3]. The predominant clinical features of FD are attributable to
paralysis of the entire gastrointestinal tract caused by severe enteric neuropathy [3]. Striking
similarities in the clinico-pathological features of FD with multiple system neuropathies
reported in horses (equine grass sickness; EGS), dogs (canine dysautonomia), hares (leporine
dysautonomia), rabbits, alpacas, llamas and sheep (abomasal emptying defect) suggest these
represent a specific disease entity with a common aetiology [4]. The authors are unaware of a
human neurodegenerative disorder which shares the exquisitely localised neuroanatomic
lesions of these animal diseases. The aetiology of these animal multiple system neuropathies is
unknown, although some evidence supports an association with Clostridium botulinum type
C/D [2,5–7]. There has been no investigation of the potential role of genetic mutations, such as
those which cause familial human dysautonomia [8]. Horses with acute EGS have reductions
in plasma concentrations of the sulphur amino acids (SAA) cyst(e)ine and methionine, and
perturbations in plasma amino acid profile consistent with severe protein malnutrition [9].
We hypothesise that SAA depletion in EGS may reflect xenobiotic exposure, since SAA are
strong nucleophiles that trap, reduce, detoxify and facilitate the excretion of electrophilic
compounds and free radicals derived from dietary toxins such as mycotoxins, plant lectins,
sesquiterpene lactones and toxic amino acids [10–13]. The aim of this study was to determine
whether FD cats have alterations in amino acid profiles similar to those of EGS horses. Amino
acids were quantified in plasma/serum from 14 FD cats from 3 separate premises, 5 healthy in-
contact cats which shared housing and diet with the FD cats, and 6 healthy control cats which
were housed separately from FD cats and which received a different diet. The adequacy of the
cats’ dietary amino acid intake was assessed by determining the amino acid content of 2 tinned
and 5 dry pelleted foods collected from the 3 premises immediately after occurrences of FD.
Multi-mycotoxin screening was performed on dry food from all 3 premises to determine
whether FD and altered plasma amino acid status could be associated with ingestion of a die-
tary neurotoxic mycotoxin.
Materials and methods
Sample collection
The study was approved by the School of Veterinary Medicine Ethical Review Committee, Uni-
versity of Edinburgh. Samples were collected from 3 premises shortly after occurrences of FD.
Premise A was a closed cat breeding colony in north England where previously published cases
of FD had occurred [14,15]. These publications provide detailed information on colony manage-
ment and epidemiology of previous cases. Samples were collected for the present study when an
additional 23 cats developed FD. Heparinised plasma was collected from 13 of these FD cats
(median age 11 weeks, range 8 weeks-26 months) and from 5 healthy in-contact cats (age 14
weeks, 8 weeks-36 months) which were housed with the FD cats and given the same food. FD
and in-contact cats were fed approximately 114 g/day tinned food in the morning and ad libitum
dry pellets in the afternoon (Table 1); samples of these foods were collected for analysis. Hepari-
nised plasma was also collected from 6 healthy control cats (3 males, 3 females; median age 32
weeks, range 11–36 weeks) which were housed separately on premise A. These control cats
received a different diet from the FD and in-contact cats (this diet was not analysed). Premise B
was a closed non-breeding colony in south Scotland, where 6 of 8 cats developed clinical FD, 3
of which were euthanased on humane grounds. Cats were fed dry pellets from a hopper, tinned
food and small amounts of turkey and ham. Tinned food, dry pellets (Table 1) and serum from
one FD cat (Birman, female entire, 5 years old) were collected from premise B. Food (Table 1)
was collected from Premise C, a single cat household in north Scotland. Blood samples were not
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available from cats on premise C. Detailed clinical and epidemiological information for the clus-
ters on premises B and C was published [16]. FD was confirmed by demonstrating characteristic
gross necropsy findings, and histological evidence of chromatolysis, degeneration and loss of
autonomic neurons in the cranial cervical and/or celiacomesenteric ganglia [2,3], for all FD cats
from premise A, 2/8 cats from premise B and the cat from premise C.
Blood was collected from cats within 24 h of the onset of clinical signs, centrifuged at 500g
for 10–15 min and plasma/serum stored at -70˚C prior to analysis within 2 months. Plasma
was not deproteinised prior to freezing. Prior to analysis, dry food was stored in sealed plastic
bags at –20˚C, while unopened canned food was stored at room temperature.
Plasma/serum amino acid analyses
Plasma/serum amino acid profiles were determined as previously described [9]. Tryptophan
was not detectable by this method due to losses during sample preparation and analysis. Cyste-
ine and cystine were not differentiated by this method, because cysteine was oxidised to the
disulphide cystine during analysis. The combined cysteine and cystine concentration was
therefore referred to as the cyst(e)ine concentration.
Amino acid content of food
Amino acids were quantified using acid hydrolysis, with the exception of cysteine and methio-
nine which were quantified using performic acid oxidation to convert the amino acids to the
acid stable compounds cysteic acid and methionine sulphone [18]. Protein content was
Table 1. Metabolisable energy (ME; kcal/100g), protein and amino acid (g/1000 kcal ME) content of cat foods (n = 7) collected immediately after
occurrences of FD. Also shown are [cystine + methionine] and [phenylalanine + tyrosine] concentrations. Recommended minimum nutrient requirements for
growing and breeding cats (g/1000 kcal ME) are derived from the FEDIAF (2014) Nutritional Guidelines for Complete and Complementary Pet Food for Cats
and Dogs [17].
Premise A
Tinned food
Premise A
Dry pellets
Premise B
Tinned food
Premise B
Dry pellets
Premise C
Dry pellets 1
Premise C
Dry pellets 2
Premise C
Dry pellets 3
Recommended
minimum requirement
ME 78 333 66 448 346 326 326 -
Protein 105 94 121 68 91 94 104 70/75
Alanine 6.0 5.8 8.3 4.4 6.6 5.9 6.3 -
Arginine 7.8 5.7 12.1 6.3 5.7 7.4 8.0 2.68/2.78
Aspartic Acid 8.2 7.2 11.1 6.0 6.1 7.4 7.9 -
Cystine 0.5 1.2 1.1 0.9 1.5 1.2 1.2 -
Glutamic Acid 12.3 17.5 17.0 10.1 18.9 16.3 16.6 -
Glycine 8.5 6.3 12.0 6.0 4.3 7.1 8.1 -
Histidine 2.4 2.1 3.2 1.6 2.0 2.3 2.3 0.83
Isoleucine 3.5 3.3 4.7 2.9 3.6 3.8 3.8 1.35
Leucine 7.2 8.0 9.2 5.3 11.0 8.2 8.2 3.20
Lysine 5.9 4.2 8.6 4.1 2.8 4.7 5.0 2.13
Methionine 1.8 1.7 2.3 2.1 1.9 1.8 2.1 1.10
Phenylalanine 3.8 4.1 5.2 2.8 4.9 4.4 4.3 1.25
Proline 5.6 7.0 8.0 4.8 7.5 6.9 6.9 -
Serine 3.8 4.1 5.3 3.9 4.6 4.4 4.4 -
Threonine 3.6 3.2 5.0 2.9 3.2 3.6 3.6 1.63
Tyrosine 2.9 3.0 3.9 2.2 4.0 3.3 3.3 -
Valine 5.0 4.2 6.5 3.8 4.3 4.6 4.6 1.60
Meth + Cys 2.3 2.8 3.3 3.0 3.5 3.0 3.3 2.20
Phe + Tyr 6.8 7.1 9.1 5.0 12.6 7.7 7.5 4.78
https://doi.org/10.1371/journal.pone.0174346.t001
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calculated using the Kjeldahl technique [19]. Protein and amino acid content were expressed
as g/1000 kcal metabolisable energy (ME), using the manufacturers’ stated ME values for each
food. The adequacy of the protein and amino acid content of foods was determined using the
FEDIAF Nutritional Guidelines for Complete and Complementary Pet Food for Cats and
Dogs (2014) [17] and the National Research Council (NRC) Nutrient Requirements for Dogs
and Cats (2016) [20].
Multi-mycotoxin screening of dry food
Dry cat food from all 3 premises was subjected to multi-mycotoxin screening using published
LC-MS/MS methodology [21]. In brief, this involved extraction of samples on a shaker with a
mixture of acetonitrile water acetic acid (79 20 1). After centrifugation, an aliquot of the test
sample extract was diluted with an equal volume of a mixture of acetonitrile water acetic acid
(20 79 1). This was filtered through 0.2μm pore size nylon syringe filter before analysis by
UPLC-MS/MS. Two chromatography runs were required to determine all mycotoxins, the
majority of compounds were run using a neutral mobile phase gradient. The remaining com-
pounds (fumonisins, ochratoxin A, citrinin and alternaria toxins) were analysed using acidic
conditions. Samples were analysed as received and spiked at the Level of Interest, this was used
to determine individual reporting limits. The 72 mycotoxins tested for and their respective
reporting limits are listed in S1 Table.
Statistical analysis
As the concentrations of all serum amino acids for the single FD cat from premise B were
within the ranges for plasma amino acids for the 13 FD cats from premise A, data for all 14 FD
cats were pooled for analysis. As data were non-normally distributed, the Mann Whitney Test
was used for inter-group comparisons. For statistical analysis, values below the appropriate
detection limits (<5uM or <10uM) were considered to be 4.9uM and 9.9uM, respectively. As
the inter-group comparison of plasma amino acid concentrations involved numerous (n = 63)
statistical comparisons, a significance level of p<0.01 was used to reduce the probability of sig-
nificant differences occurring due to chance.
Results
Plasma/serum amino acid data are summarised in Table 2, with data for individual cats being
given in S2 Table.
Comparison of data from the three groups of cats facilitates evaluation of some of the
potential factors which could influence amino acid status. Differences in amino acid status
between FD and control cats could reflect differences in diet or management, direct effects of
the putative causal neurotoxin or the numerous metabolic perturbations resulting from clinical
FD including anorexia, tissue catabolism and gastrointestinal ileus. Differences between FD
and in-contact cats could reflect differences in magnitude of exposure to the putative neuro-
toxin or the secondary clinical consequences of FD. Differences between in-contact and con-
trol cats could reflect differences in diet or management, or the effects of potential sub-clinical
exposure of the in-contact cats to the putative neurotoxin which causes FD.
Plasma/serum amino acid concentrations for control cats were generally similar to those
reported previously [22–24], except for artefactual alterations in cyst(e)ine and glutamate con-
centrations. Cyst(e)ine concentrations were lower than previously reported (75 ± 3 μmol/L
[22]; 75 ± 2 μmol/L [23]; >40 μmol/L [25]). Cyst(e)ine was undetectable in 5 FD and 2 in-con-
tact cats. Most cats had higher glutamate concentrations than previously reported (72 ± 19
μmol/L [23]; 32 μmol/L [25]).
Amino acid status in feline dysautonomia
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Compared with controls, FD cats had significantly increased concentrations of isoleucine
(p<0.001), leucine (p<0.005), lysine (p<0.001), ornithine, threonine (p<0.01) and valine
(p<0.001), and significantly decreased concentrations of glutamine and methionine (p<
0.005). Compared with in-contacts, FD cats had significantly increased concentrations of
lysine, ornithine and valine (p<0.005) and significantly decreased concentrations of aspartate
(p<0.01) and glutamate (p<0.005). Compared with controls, in-contact cats had significantly
increased concentrations of glutamate, and significantly reduced concentrations of glutamine
and methionine (p<0.01).
Methionine concentrations for FD and in-contact cats were markedly lower than reported
previously for healthy cats (range 65 ± 12 μmol/L [22]; 66 ± 8 μmol/L [23]; 75 ± 34 μmol/L
[26]; 101.1 ± 8.85 μmol/L [27]). Methionine was limiting (<30 μmol/L [20]) in 3 in-contacts,
one of which had an undetectable methionine concentration (S2 Table). Methionine concen-
trations of these 3 in-contact cats approximated those of kittens fed diets lacking in methionine
(11 μmol/L [20]). Tyrosine concentrations were limiting (<35 μmol/L [20]) in 5 FD, 2 in-con-
tact and 2 control cats (S2 Table). Arginine was limiting (<75 μmol/L [20]) in 4 FD, 2 in-con-
tact and 2 control cats (S2 Table).
Data for food analyses are given in Table 1. The protein and essential amino acid content of
all 7 foods exceeded FEDIAF (2014) [17] minimum recommended levels for growing kittens.
Tinned food from premise B had an arginine content (12.1 g/1000 kcal ME) exceeding the
NRC 2006 [20] recommended upper limit (8.75 g/1000 kcal ME). Dry pellets 1 from premise
Table 2. Concentrations of amino acids (μmol/L) in plasma/serum from FD (n = 14), in-contact (n = 5) and control cats (n = 6).
FD IN-CONTACTS CONTROLS
Alanine 450 (249–894) 725 (399–957) 486 (278–694)
Arginine 135 (26–246) 101 (54–182) 98 (50–115)
Aspartate 37 (19–97) c 92 (62–116) c 65 (33–89)
Cyst(e)ine 11 (<5–35) 15 (<10–22) <10 (<10-<10)
Glutamate 98 (46–179) b 478 (298–532) bc 109 (19–124) c
Glutamine 489 (346–912)b 437 (266–550) c 843 (729–1323) bc
GLU + GLN 576 (444–958) 848 (744–996) 949 (748–1435)
Glycine 398 (244–902) 487 (349–626) 606 (360–880)
Histidine 107 (59–169) 101 (69–143) 105 (71–167)
Isoleucine 98 (53–137) a 73 (40–87) 38 (24–59) a
Leucine 180 (133–230) b 163 (85–234) 108 (53–156) b
Lysine 201 (140–321) ab 117 (62–138) b 94 (64–120) a
Methionine 49 (33–90) b 11 (<10–64) c 77 (65–122) bc
Ornithine 69 (24–258) bc 36 (33–53) b 34 (29–39) c
Phenylalanine 73 (58–107) b 53 (39–60) b 61 (49–80)
Serine 233 (145–432) 280 (236–352) 238 (193–650)
Taurine 204 (67–489) 211 (116–276) 115 (60–179)
Threonine 172 (126–294) c 157 (133–219) 121 (105–155) c
Tyrosine 42 (28–75) 28 (25–63) 42 (27–59)
Valine 287 (225–369) ab 151 (128–253) b 121 (83–159) a
a significant difference between pairs (p<0.001)
b significant difference between pairs (p<0.005)
c significant difference between pairs (p<0.01).
GLU + GLN—sum of glutamate and glutamine concentrations.
https://doi.org/10.1371/journal.pone.0174346.t002
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C had a glutamic acid content (18.9 g/1000 kcal ME) just exceeding the NRC 2006 [20] recom-
mended upper limit (18.8 g/1000 kcal ME).
Dry cat food from all 3 premises contained beauvericin, deoxynivalenol, enniatins (A1, B
and B1), fumonisin (B1, B2 and B3), fusarenon X and zearalenone (Table 3). Deoxynivalenol-
3-glucoside was also detected in feed from premises 1 and 3 and mycophenolic acid was also
detected in feed from premises 2 and 3 (Table 3).
Discussion
Cats with FD had significant alterations in plasma/serum amino acid status when compared
with clinically healthy in-contact and control cats. Compared with controls, FD cats had signif-
icantly increased concentrations of many essential amino acids, with the exception of methio-
nine which was significantly reduced, and reductions in most non-essential amino acids. The
increase in essential amino acids in FD may reflect increased tissue protein catabolism in
response to reduced food intake. In contrast, horses with EGS had reduced plasma concentra-
tions of many essential amino acids, consistent with severe protein malnutrition, and increased
concentrations of some non-essential amino acids [9].
Perhaps the most notable finding was low plasma/serum concentrations of methionine in
FD and in-contact cats. Indeed methionine was undetectable (<10 μmol/L) in plasma from
one in-contact cat, while 2 other in-contact cats had only 11 μmol/L methionine which equates
to the plasma methionine concentration of kittens fed diets lacking methionine [20,25]. Methi-
onine is an essential amino acid for cats, although cysteine may supply approximately 50% of
this requirement [28]. Many of the FD cats in this study were young growing cats which have a
higher SAA requirement than adults [20].
The low concentrations of methionine noted in FD and in-contact cats is consistent the
depletion of methionine and cyst(e)ine reported in EGS and healthy in-contact horses [9]. In
the present study it was unfortunately not possible to meaningful assess the cats’ cyst(e)ine sta-
tus because the low plasma/serum cyst(e)ine concentrations noted in all cats were likely arte-
factual, due to cysteine interaction with sulphydryl groups on plasma proteins and subsequent
loss when the protein was precipitated during sample preparation. This loss occurs rapidly in
feline plasma/serum that is not deproteinised immediately after collection [29].
While methionine is generally the limiting amino acid for feline diets that are formulated
using natural ingredients [20], the low methionine noted in FD and in-contact cats is unlikely
Table 3. Concentrations of mycotoxins (μg/kg) in dry food from the 3 premises. Data are concentrations measured in 3 aliquots of each sample.
Mycotoxin Premise 1 Premise 2 Premise 3
Beauvericin 600 601 601 557 566 562 524 574 549
Deoxynivalenol 241 232 236 7 11 9 3 5 4
Deoxynivalenol-3-Glucoside 28 26 27 - - - 0 11 5
Emodin - - - 30 43 37 72 33 53
Enniatin A1 5 5 5 6 6 6 8 10 9
Enniatin B 35 33 34 19 18 19 19 23 21
Enniatin B1 35 36 36 30 29 30 31 41 36
Fumonisin B1 180 146 163 44 46 45 39 39 39
Fumonisin B2 118 121 119 72 73 73 63 65 64
Fumonisin B3 37 35 36 22 22 22 20 21 21
Fusarenon X 17 15 16 30 29 29 15 20 17
Mycophenolic Acid - - - 18 17 17 16 17 16
Zearalenone 72 79 76 22 20 21 17 15 16
https://doi.org/10.1371/journal.pone.0174346.t003
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to reflect inadequate dietary intake since the methionine, cystine and [methionine + cysteine]
content of all foods tested exceeded the minimum requirements for growing kittens [17]. This
assumes that the bioavailability of amino acids in the foods is adequate. Since healthy in-con-
tact horses and cats also had low plasma SAA levels, this anomaly cannot simply be a conse-
quence of anorexia or of the numerous metabolic disturbances that develop secondarily to the
multiple system neuropathy. Instead, we hypothesise that SAA depletion may reflect exposure
of FD and in-contact cats to xenobiotics, since SAA are strong nucleophiles that trap, reduce,
detoxify and facilitate the excretion of electrophilic compounds and free radicals derived from
dietary toxins such as mycotoxins, plant lectins, sesquiterpene lactones and toxic amino acids
[10–13]. Previous epidemiological investigations on all three premises [14–16], and of other
FD clusters [3,30–31] have failed to identify potential causal xenobiotics with the exception of
Clostridium botulinum type C neurotoxin [32]. While there is an association between C. botuli-
num and both FD and EGS [5–7], this does not prove causality, and the authors are unaware
of a biologically plausible link between low SAA status and toxic-infection with C. botulinum.
Interestingly, the prolonged occurrence of multiple cases of FD on premise A ceased when the
diet previously fed to the FD and in-contact cats was replaced, the environment disinfected
and the breeding toms replaced. There were no further occurrences of FD in Premise A follow-
ing these interventions. While it is unclear which of these interventions was protective, we con-
sider that removal of a dietary xenobiotic, such as a neurotoxic mycotoxin, produced by
microbes contaminating the dry pelleted food in the feed hoppers, is most likely.
To test the hypothesis that FD and the associated alterations in plasma amino acid status
were attributable to ingestion of mycotoxins in the dry food, multi-mycotoxin analyses were
performed on dry food from all 3 premises. All samples contained beauvericin, deoxynivale-
nol, enniatins (A1, B and B1), fumonisin (B1, B2 and B3), fusarenon X and zearalenone, while
deoxynivalenol-3-glucoside and mycophenolic acid were also detected in food from 2 prem-
ises. Consistent with these data, previous studies have identified mycotoxins in a high propor-
tion of pet food samples, with the mycotoxin profiles and levels being comparable to those
reported herein [33–36]. The mycotoxin profile identified in all foods was consistent with
Fusarium spp. contamination [37,38]. Fungal contamination may have occurred post-manu-
facture or may reflect fungal contamination of raw ingredients such as cereals, since deoxyni-
valenol is stable during extrusion processing of cat feed [39].
We consider it unlikely that the any of mycotoxins detected caused FD. Firstly, all detected
mycotoxins were present only at low levels, well below the guidance limits for cat foods (limits
are available only for T2, HT2 toxin and ochratoxin A) and for other pet foods [39–44]. Sec-
ondly, only deoxynivalenol and the fumonisins have reported neurotoxic effects in vivo [42,
45–47]. While some of the clinical signs of FD could theoretically be attributed to the actions
of one of these neurotoxic mycotoxins; for example, profound anorexia and swallowing defi-
cits have been associated with deoxynivalenol ingestion in other species [45,46], the reported
clinico-pathological consequences of their ingestion differ from those associated with FD
[2,3]. Further work is required to test our hypothesis that FD is caused by another neurotoxic
mycotoxin or xenobiotic present in the dry food which was not detected using the multi-
mycotoxin screen.
We hypothesise that depletion of SAA in FD reflects glutathione-mediated hepatic detoxifi-
cation of mycotoxins or other xenobiotics. Since glutathione contains cystine, a derivative of
methionine, this process may deplete SAA, while methionine supplementation can attenuate
the detrimental effects of mycotoxins [10–13,48].
Since methionine is required for protein synthesis, as a methyl group donor, and part of
the coenzyme (S-adenosylmethionine) for methyl group transfer, methionine deficiency
results in a multitude of metabolic aberrations [20]. Whether low SAA status contributes to
Amino acid status in feline dysautonomia
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the neurodegeneration in FD and EGS is unknown. However, methionine deficiency cannot be
the sole cause of FD since removal of methionine from the diet of kittens and adult cats caused
weight loss, lethargy, and excessive ocular secretions [24,49,50] but did not produce signs sug-
gestive of FD. Consequently we hypothesise that FD is caused by the direct neurotoxic effects of
a dietary mycotoxin or xenobiotic rather than by the associated depletion of methionine.
The majority of cats had glutamate concentrations exceeding the reference range (50–
100 μmol/L [20]). This probably reflects artefactual contamination of plasma/sera with gluta-
mate-rich platelets [51], rather than a real effect on glutamate metabolism. Consistent with this
possibility, equine plasma had excessively high glutamate concentrations unless harvested by
ultracentrifugation [9]. Arginine, which is essential for cats, was limiting in 4 FD, 2 in-contact
and 2 control cats. However, in-contact and control cats showed no signs of arginine defi-
ciency, which include anorexia, severe weight loss, diarrhoea and hyperammonemia [52,53].
While tyrosine concentrations were limiting in 5 FD, 2 in-contact and 2 control cats, these cats
had no signs of tyrosine deficiency, which include weight loss, hair pigment change, hyperac-
tivity, excessive vocalisation, hypersalivation and ataxia [54,55].
Conclusions
The reduction in plasma/serum concentrations of methionine in FD and in-contact cats is
consistent with the reduction in plasma SAA (cysteine and methionine) concentrations in
horses with acute EGS. Food analysis indicated that the low methionine status in FD and in-
contact cats is unlikely to be attributable to dietary inadequacy of methionine and/or cystine.
Several mycotoxins were detected at low levels in dry food from 3 premises, however none of
these appears to induce the specific clinico-pathologic features which characterise FD. Further
work is required to test our hypothesis that FD, and the low SAA status of FD cats, EGS horses
and in-contact animals, reflects exposure to an unidentified neurotoxic mycotoxin or
xenobiotic.
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